384 related articles for article (PubMed ID: 17618986)
1. Traumatic brain injury and Alzheimer's disease: a review.
Van Den Heuvel C; Thornton E; Vink R
Prog Brain Res; 2007; 161():303-16. PubMed ID: 17618986
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
[TBL] [Abstract][Full Text] [Related]
4. Traumatic brain injury: a risk factor for Alzheimer's disease.
Sivanandam TM; Thakur MK
Neurosci Biobehav Rev; 2012 May; 36(5):1376-81. PubMed ID: 22390915
[TBL] [Abstract][Full Text] [Related]
5. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans.
DeKosky ST; Abrahamson EE; Ciallella JR; Paljug WR; Wisniewski SR; Clark RS; Ikonomovic MD
Arch Neurol; 2007 Apr; 64(4):541-4. PubMed ID: 17420316
[TBL] [Abstract][Full Text] [Related]
6. Risk and protective factors for sporadic Alzheimer's disease.
Stozická Z; Zilka N; Novák M
Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
8. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
[TBL] [Abstract][Full Text] [Related]
9. Can chronic increased intracranial pressure or exposure to repetitive intermittent intracranial pressure elevations raise your risk for Alzheimer's disease?
Wostyn P
Med Hypotheses; 2004; 62(6):925-30. PubMed ID: 15142650
[TBL] [Abstract][Full Text] [Related]
10. Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats.
Iwata A; Browne KD; Chen XH; Yuguchi T; Smith DH
J Neurosci Res; 2005 Oct; 82(1):103-14. PubMed ID: 16118797
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E, amyloid, and Alzheimer disease.
Bales KR; Dodart JC; DeMattos RB; Holtzman DM; Paul SM
Mol Interv; 2002 Oct; 2(6):363-75, 339. PubMed ID: 14993413
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for Alzheimer's disease].
Yanagisawa K
Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of the brain by pathogens causes Alzheimer's disease.
Itzhaki RF; Wozniak MA; Appelt DM; Balin BJ
Neurobiol Aging; 2004; 25(5):619-27. PubMed ID: 15172740
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E and Alzheimer disease.
Huang Y
Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
[TBL] [Abstract][Full Text] [Related]
15. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
16. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
17. A beta oligomers - a decade of discovery.
Walsh DM; Selkoe DJ
J Neurochem; 2007 Jun; 101(5):1172-84. PubMed ID: 17286590
[TBL] [Abstract][Full Text] [Related]
18. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
19. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
[TBL] [Abstract][Full Text] [Related]
20. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.
Bertram L; Tanzi RE
Nat Rev Neurosci; 2008 Oct; 9(10):768-78. PubMed ID: 18802446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
